Literature DB >> 2434953

Isolation of temperature-sensitive tyrosine kinase mutants of v-abl oncogene by screening with antibodies for phosphotyrosine.

E T Kipreos, G J Lee, J Y Wang.   

Abstract

Temperature-sensitive protein-tyrosine kinase (EC 2.7.1.112) mutants of the oncogene v-abl have been obtained by a direct screening of kinase mutants in bacteria. The v-abl oncogene was expressed in Escherichia coli as a trpE/v-abl fusion protein from the trp promoter. The expression plasmid was mutagenized in vitro and then transfected into E. coli. Bacteria that produced defective tyrosine kinases were distinguished from those producing wild-type v-abl kinases by hybridization with antibodies specific for phosphotyrosine. Two independent mutations that generated temperature-sensitive tyrosine kinases were found to be located in a 12-amino acid region in the tyrosine kinase domain of the v-abl-encoded protein. These mutant v-abl oncogenes displayed temperature-sensitive transforming activity when expressed in NIH 3T3 cells. Cells transformed by these temperature-sensitive tyrosine kinase mutants could be shifted between the transformed and untransformed states by changing their growth temperature. These results confirmed the crucial role of tyrosine kinase activity in the v-abl-mediated oncogenesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2434953      PMCID: PMC304425          DOI: 10.1073/pnas.84.5.1345

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  Direct transformation of 3T3 cells by Abelson murine leukaemia virus.

Authors:  C D Scher; R Siegler
Journal:  Nature       Date:  1975-02-27       Impact factor: 49.962

2.  Isolation of antibodies for phosphotyrosine by immunization with a v-abl oncogene-encoded protein.

Authors:  J Y Wang
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

3.  Two independent mutations are required for temperature-sensitive cell transformation by a Rous sarcoma virus temperature-sensitive mutant.

Authors:  M Nishizawa; B J Mayer; T Takeya; T Yamamoto; K Toyoshima; H Hanafusa; S Kawai
Journal:  J Virol       Date:  1985-12       Impact factor: 5.103

Review 4.  Viral oncogenes.

Authors:  J M Bishop
Journal:  Cell       Date:  1985-08       Impact factor: 41.582

Review 5.  Protein-tyrosine kinases.

Authors:  T Hunter; J A Cooper
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

6.  Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.

Authors:  Y Yarden; J A Escobedo; W J Kuang; T L Yang-Feng; T O Daniel; P M Tremble; E Y Chen; M E Ando; R N Harkins; U Francke
Journal:  Nature       Date:  1986 Sep 18-24       Impact factor: 49.962

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

8.  The minimum transforming region of v-abl is the segment encoding protein-tyrosine kinase.

Authors:  R Prywes; J G Foulkes; D Baltimore
Journal:  J Virol       Date:  1985-04       Impact factor: 5.103

9.  A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family.

Authors:  P Besmer; J E Murphy; P C George; F H Qiu; P J Bergold; L Lederman; H W Snyder; D Brodeur; E E Zuckerman; W D Hardy
Journal:  Nature       Date:  1986 Apr 3-9       Impact factor: 49.962

10.  Rous sarcoma virus transforming protein lacking myristic acid phosphorylates known polypeptide substrates without inducing transformation.

Authors:  M P Kamps; J E Buss; B M Sefton
Journal:  Cell       Date:  1986-04-11       Impact factor: 41.582

View more
  16 in total

1.  Insertional mutagenesis of the Abelson murine leukemia virus genome: identification of mutants with altered kinase activity and defective transformation ability.

Authors:  R W Rees-Jones; S P Goff
Journal:  J Virol       Date:  1988-03       Impact factor: 5.103

2.  Carboxyl-terminal determinants of Abelson protein important for lymphoma induction.

Authors:  K Parmar; R C Huebner; N Rosenberg
Journal:  J Virol       Date:  1991-12       Impact factor: 5.103

3.  Isolation of temperature-sensitive Abelson virus mutants by site-directed mutagenesis.

Authors:  A Engelman; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

4.  DNA sequence, structure, and tyrosine kinase activity of the Drosophila melanogaster Abelson proto-oncogene homolog.

Authors:  M J Henkemeyer; R L Bennett; F B Gertler; F M Hoffmann
Journal:  Mol Cell Biol       Date:  1988-02       Impact factor: 4.272

5.  Role of tyrosine kinase and membrane-spanning domains in signal transduction by the platelet-derived growth factor receptor.

Authors:  J A Escobedo; P J Barr; L T Williams
Journal:  Mol Cell Biol       Date:  1988-12       Impact factor: 4.272

6.  Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

Authors:  M A Kelliher; J McLaughlin; O N Witte; N Rosenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1990-09       Impact factor: 11.205

7.  Temperature-sensitive mutants of Abelson murine leukemia virus deficient in protein tyrosine kinase activity.

Authors:  A Engelman; N Rosenberg
Journal:  J Virol       Date:  1990-09       Impact factor: 5.103

8.  Multiple steps are required for the induction of tumors by Abelson murine leukemia virus.

Authors:  P L Green; D A Kaehler; L M Bennett; R Risser
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Tyrosine kinase oncogenes abrogate interleukin-3 dependence of murine myeloid cells through signaling pathways involving c-myc: conditional regulation of c-myc transcription by temperature-sensitive v-abl.

Authors:  J L Cleveland; M Dean; N Rosenberg; J Y Wang; U R Rapp
Journal:  Mol Cell Biol       Date:  1989-12       Impact factor: 4.272

10.  Delineation of functional determinants in the transforming protein of Fujinami sarcoma virus.

Authors:  K A Johnson; J C Stone
Journal:  J Virol       Date:  1990-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.